Novocure Change Receivables from 2010 to 2024
| NVCR Stock | USD 12.24 0.56 4.38% |
Change Receivables | First Reported 2017-03-31 | Previous Quarter 14.5 M | Current Value 6.9 M | Quarterly Volatility 7.5 M |
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 3.2 M or Selling General Administrative of 87.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 4.16. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
Novocure | Change Receivables |
Latest Novocure's Change Receivables Growth Pattern
Below is the plot of the Change Receivables of Novocure over the last few years. It is the difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease. Novocure's Change Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
| Change Receivables | 10 Years Trend |
|
Change Receivables |
| Timeline |
Novocure Change Receivables Regression Statistics
| Arithmetic Mean | (8,318,696) | |
| Coefficient Of Variation | (147.43) | |
| Mean Deviation | 8,682,921 | |
| Median | (6,339,000) | |
| Standard Deviation | 12,263,949 | |
| Sample Variance | 150.4T | |
| Range | 41.8M | |
| R-Value | 0.11 | |
| Mean Square Error | 160.1T | |
| R-Squared | 0.01 | |
| Significance | 0.70 | |
| Slope | 293,589 | |
| Total Sum of Squares | 2105.7T |
Novocure Change Receivables History
About Novocure Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Novocure income statement, its balance sheet, and the statement of cash flows. Novocure investors use historical funamental indicators, such as Novocure's Change Receivables, to determine how well the company is positioned to perform in the future. Although Novocure investors may use each financial statement separately, they are all related. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Novocure's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Novocure Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Novocure. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change Receivables | 2.9 M | 3.1 M |
Novocure Investors Sentiment
The influence of Novocure's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Novocure. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Novocure's public news can be used to forecast risks associated with an investment in Novocure. The trend in average sentiment can be used to explain how an investor holding Novocure can time the market purely based on public headlines and social activities around Novocure. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Novocure's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Novocure's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Novocure's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Novocure.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novocure in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novocure's short interest history, or implied volatility extrapolated from Novocure options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Novocure Correlation against competitors. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.Note that the Novocure information on this page should be used as a complementary analysis to other Novocure's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Novocure Stock analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Novocure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share (1.95) | Revenue Per Share 4.787 | Quarterly Revenue Growth 0.042 | Return On Assets (0.12) |
The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.